Dai ichi Life Insurance Company Ltd trimmed its position in CME Group Inc. (NASDAQ:CME - Free Report) by 12.8% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 51,243 shares of the financial services provider's stock after selling 7,527 shares during the period. Dai ichi Life Insurance Company Ltd's holdings in CME Group were worth $11,307,000 as of its most recent SEC filing.
Other institutional investors also recently bought and sold shares of the company. Harbor Capital Advisors Inc. boosted its holdings in CME Group by 0.6% during the third quarter. Harbor Capital Advisors Inc. now owns 7,810 shares of the financial services provider's stock worth $1,723,000 after buying an additional 45 shares in the last quarter. CVA Family Office LLC grew its holdings in shares of CME Group by 11.8% in the 3rd quarter. CVA Family Office LLC now owns 436 shares of the financial services provider's stock worth $96,000 after acquiring an additional 46 shares during the period. Lester Murray Antman dba SimplyRich increased its stake in CME Group by 0.7% in the 2nd quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider's stock valued at $1,507,000 after purchasing an additional 50 shares in the last quarter. Zions Bancorporation N.A. raised its holdings in CME Group by 3.7% during the third quarter. Zions Bancorporation N.A. now owns 1,530 shares of the financial services provider's stock worth $338,000 after purchasing an additional 54 shares during the last quarter. Finally, Quent Capital LLC grew its holdings in CME Group by 10.2% in the third quarter. Quent Capital LLC now owns 593 shares of the financial services provider's stock valued at $131,000 after purchasing an additional 55 shares during the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling
In other CME Group news, Director Martin J. Gepsman sold 400 shares of the stock in a transaction on Monday, November 4th. The stock was sold at an average price of $222.92, for a total transaction of $89,168.00. Following the completion of the transaction, the director now directly owns 25,067 shares of the company's stock, valued at approximately $5,587,935.64. This trade represents a 1.57 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Lynne Fitzpatrick sold 754 shares of the business's stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the sale, the chief financial officer now directly owns 13,261 shares in the company, valued at $2,877,504.39. This represents a 5.38 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 15,621 shares of company stock valued at $3,441,063 in the last three months. 0.30% of the stock is currently owned by corporate insiders.
CME Group Stock Up 1.9 %
Shares of NASDAQ:CME traded up $4.32 during midday trading on Tuesday, reaching $233.69. The company had a trading volume of 1,572,315 shares, compared to its average volume of 1,921,327. The stock has a market capitalization of $84.21 billion, a P/E ratio of 24.12, a PEG ratio of 5.28 and a beta of 0.55. The stock's fifty day moving average price is $223.86 and its 200-day moving average price is $211.19. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a one year low of $190.70 and a one year high of $233.70.
CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The business had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same quarter in the previous year, the firm posted $2.25 EPS. The business's revenue for the quarter was up 18.4% compared to the same quarter last year. Equities research analysts expect that CME Group Inc. will post 10.22 earnings per share for the current fiscal year.
CME Group Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Monday, December 9th will be given a dividend of $1.15 per share. The ex-dividend date is Monday, December 9th. This represents a $4.60 annualized dividend and a dividend yield of 1.97%. CME Group's dividend payout ratio is presently 48.37%.
Wall Street Analysts Forecast Growth
CME has been the subject of several research reports. Piper Sandler lifted their price target on CME Group from $240.00 to $250.00 and gave the stock an "overweight" rating in a research note on Monday, October 28th. Barclays upped their price target on shares of CME Group from $219.00 to $231.00 and gave the company an "equal weight" rating in a report on Thursday, October 24th. Redburn Atlantic cut shares of CME Group from a "buy" rating to a "neutral" rating and set a $244.00 price objective for the company. in a research note on Tuesday, October 8th. The Goldman Sachs Group upped their target price on CME Group from $195.00 to $198.00 and gave the company a "sell" rating in a research note on Thursday, October 3rd. Finally, Morgan Stanley raised their price target on shares of CME Group from $210.00 to $233.00 and gave the stock an "equal weight" rating in a research note on Thursday, October 17th. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $224.47.
Read Our Latest Research Report on CME
About CME Group
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Further Reading
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.